Technical Analysis for HYPR - Hyperfine, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Centerline Cross | Bullish | 0.00% | |
180 Bullish Setup | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Fell Below 20 DMA | Bearish | 8.07% | |
50 DMA Support | Bullish | 8.07% | |
Upper Bollinger Band Touch | Strength | 8.07% | |
Crossed Above 20 DMA | Bullish | -3.82% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 4 hours ago |
2x Volume Pace | about 4 hours ago |
Possible Pocket Pivot | about 4 hours ago |
1.5x Volume Pace | about 5 hours ago |
Possible NR7 | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine's portable Swoop™ system is the world's first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.28 |
52 Week Low | 0.7613 |
Average Volume | 93,591 |
200-Day Moving Average | 1.17 |
50-Day Moving Average | 0.85 |
20-Day Moving Average | 0.87 |
10-Day Moving Average | 0.85 |
Average True Range | 0.08 |
RSI (14) | 54.75 |
ADX | 29.66 |
+DI | 18.31 |
-DI | 6.80 |
Chandelier Exit (Long, 3 ATRs) | 0.73 |
Chandelier Exit (Short, 3 ATRs) | 1.04 |
Upper Bollinger Bands | 0.95 |
Lower Bollinger Band | 0.79 |
Percent B (%b) | 0.81 |
BandWidth | 18.45 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0057 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.02 | ||||
Resistance 3 (R3) | 1.01 | 0.97 | 1.00 | ||
Resistance 2 (R2) | 0.97 | 0.95 | 0.97 | 1.00 | |
Resistance 1 (R1) | 0.95 | 0.93 | 0.96 | 0.95 | 0.99 |
Pivot Point | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
Support 1 (S1) | 0.88 | 0.88 | 0.89 | 0.89 | 0.85 |
Support 2 (S2) | 0.84 | 0.86 | 0.84 | 0.84 | |
Support 3 (S3) | 0.81 | 0.84 | 0.84 | ||
Support 4 (S4) | 0.82 |